Inter J Stomatol ›› 2017, Vol. 44 ›› Issue (1): 108-113.doi: 10.7518/gjkq.2017.01.022
• ·Reviews· • Previous Articles Next Articles
Liu Runheng, Liu Yudong, Chen Zhuofan.
CLC Number:
[1] Sriram M, Sainitya R, Kalyanaraman V, et al. Bio-materials mediated microRNA delivery for bone tissue engineering[J]. Int J Biol Macromol, 2015, 74: 404-412. [2] Dong S, Yang B, Guo H, et al. MicroRNAs regulate osteogenesis and chondrogenesis[J]. Biochem Bio-phys Res Commun, 2012, 418(4):587-591. [3] Hutvágner G, McLachlan J, Pasquinelli AE, et al. A cellular function for the RNA-interference enzyme dicer in the maturation of the let-7 small temporal RNA[J]. Science, 2001, 293(5531):834-838. [4] Bartel DP. MicroRNAs: genomics, biogenesis, me-chanism, and function[J]. Cell, 2004, 116(2):281- 297. [5] Hassan MQ, Tye CE, Stein GS, et al. Non-coding RNAs: epigenetic regulators of bone development and homeostasis[J]. Bone, 2015, 81:746-756. [6] Nakashima K, Zhou X, Kunkel G, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone for-mation[J]. Cell, 2002, 108(1):17-29. [7] Baglìo SR, Devescovi V, Granchi D, et al. Micro-RNA expression profiling of human bone marrow mesenchymal stem cells during osteogenic dif-ferentiation reveals osterix regulation by miR-31[J]. Gene, 2013, 527(1):321-331. [8] Shi K, Lu J, Zhao Y, et al. MicroRNA-214 suppre-sses osteogenic differentiation of C2C12 myoblast cells by targeting osterix[J]. Bone, 2013, 55(2):487- 494. [9] Li E, Zhang J, Yuan T, et al. MiR-143 suppresses osteogenic differentiation by targeting osterix[J]. Mol Cell Biochem, 2014, 390(1/2):69-74. [10] Liu H, Sun Q, Wan C, et al. MicroRNA-338-3p regulates osteogenic differentiation of mouse bone marrow stromal stem cells by targeting Runx2 and Fgfr2[J]. J Cell Physiol, 2014, 229(10):1494-1502. [11] Zuo B, Zhu J, Li J, et al. microRNA-103a functions as a mechanosensitive microRNA to inhibit bone formation through targeting Runx2[J]. J Bone Miner Res, 2015, 30(2):330-345. [12] Panchision DM, Pickel JM, Studer L, et al. Sequen-tial actions of BMP receptors control neural pre-cursor cell production and fate[J]. Genes Dev, 2001, 15(16):2094-2110. [13] Kato RB, Roy B, de Oliveira FS, et al. Nanotopo-graphy directs mesenchymal stem cells to osteoblast lineage through regulation of microRNA-SMAD-BMP-2 circuit[J]. J Cell Physiol, 2014, 229(11): 1690-1696. [14] Wu T, Zhou H, Hong Y, et al. miR-30 family mem-bers negatively regulate osteoblast differentiation[J]. J Biol Chem, 2012, 287(10):7503-7511. [15] Krzeszinski JY, Wei W, Huynh H, et al. miR-34a blocks osteoporosis and bone metastasis by inhibi-ting osteoclastogenesis and Tgif2[J]. Nature, 2014, 512(7515):431-435. [16] Moorthi A, Vimalraj S, Avani C, et al. Expression of microRNA-30c and its target genes in human osteo-blastic cells by nano-bioglass ceramic-treatment[J]. Int J Biol Macromol, 2013, 56:181-185. [17] Kureel J, Dixit M, Tyagi AM, et al. miR-542-3p suppresses osteoblast cell proliferation and differen-tiation, targets BMP-7 signaling and inhibits bone formation[J]. Cell Death Dis, 2014, 5:e1050. [18] Hupkes M, Sotoca AM, Hendriks JM, et al. Micro-RNA miR-378 promotes BMP2-induced osteogenic differentiation of mesenchymal progenitor cells[J]. BMC Mol Biol, 2014, 15:1. [19] Liao YH, Chang YH, Sung LY, et al. Osteogenic differentiation of adipose-derived stem cells and calvarial defect repair using baculovirus-mediated co-expression of BMP-2 and miR-148b[J]. Bioma-terials, 2014, 35(18):4901-4910. [20] Kieslinger M, Folberth S, Dobreva G, et al. EBF2 regulates osteoblast-dependent differentiation of osteoclasts[J]. Dev Cell, 2005, 9(6):757-767. [21] Wang T, Xu Z. miR-27 promotes osteoblast diffe-rentiation by modulating Wnt signaling[J]. Biochem Biophys Res Commun, 2010, 402(2):186-189. [22] Meng YB, Li X, Li ZY, et al. microRNA-21 promotes osteogenic differentiation of mesenchymal stem cells by the PI3K/β-catenin pathway[J]. J Orthop Res, 2015, 33(7):957-964. [23] Wang Q, Cai J, Cai XH, et al. miR-346 regulates osteogenic differentiation of human bone marrow-derived mesenchymal stem cells by targeting the Wnt/β-catenin pathway[J]. PLoS ONE, 2013, 8(9):e72266. [24] Vimalraj S, Selvamurugan N. MicroRNAs expre-ssion and their regulatory networks during mesen-chymal stem cells differentiation toward osteoblasts [J]. Int J Biol Macromol, 2014, 66:194-202. [25] Zhang Z, Wang J, Lü X. An integrated study of natural hydroxyapatite-induced osteogenic dif-ferentiation of mesenchymal stem cells using tran-scriptomics, proteomics and microRNA analyses[J]. Biomed Mater, 2014, 9(4):045005. [26] Mei Y, Bian C, Li J, et al. miR-21 modulates the ERK-MAPK signaling pathway by regulating SPRY2 expression during human mesenchymal stem cell differentiation[J]. J Cell Biochem, 2013, 114(6): 1374-1384. [27] Elabd C, Basillais A, Beaupied H, et al. Oxytocin controls differentiation of human mesenchymal stem cells and reverses osteoporosis[J]. Stem Cells, 2008, 26(9):2399-2407. [28] Li W, Yuan Y, Huang L, et al. Metformin alters the expression profiles of microRNAs in human pan-creatic cancer cells[J]. Diabetes Res Clin Pract, 2012, 96(2):187-195. [29] Sun J, Wang Y, Li Y, et al. Downregulation of PPARγ by miR-548d-5p suppresses the adipogenic differentiation of human bone marrow mesenchymal stem cells and enhances their osteogenic potential[J]. J Transl Med, 2014, 12:168. [30] Li CJ, Cheng P, Liang MK, et al. MicroRNA-188 regulates age-related switch between osteoblast and adipocyte differentiation[J]. J Clin Invest, 2015, 125 (4):1509-1522. [31] Palmieri A, Pezzetti F, Brunelli G, et al. Anorganic bovine bone(Bio-Oss) regulates miRNA of osteo-blast-like cells[J]. Int J Periodontics Restorative Dent, 2010, 30(1):83-87. [32] Palmieri A, Pezzetti F, Avantaggiato A, et al. Ti-tanium acts on osteoblast translational process[J]. J Oral Implantol, 2008, 34(4):190-195. [33] Palmieri A, Pezzetti F, Brunelli G, et al. Zirconium oxide regulates RNA interfering of osteoblast-like cells[J]. J Mater Sci Mater Med, 2008, 19(6):2471- 2476. [34] Chakravorty N, Ivanovski S, Prasadam I, et al. The microRNA expression signature on modified ti-tanium implant surfaces influences genetic me-chanisms leading to osteogenic differentiation[J]. Acta Biomater, 2012, 8(9):3516-3523. [35] Wang Z, Zhang D, Hu Z, et al. MicroRNA-26a-modified adipose-derived stem cells incorporated with a porous hydroxyapatite scaffold improve the repair of bone defects[J]. Mol Med Rep, 2015, 12(3): 3345-3350. [36] Deng Y, Zhou H, Gu P, et al. Repair of canine me-dial orbital bone defects with miR-31-modified bone marrow mesenchymal stem cells[J]. Invest Ophthal-mol Vis Sci, 2014, 55(9):6016-6023. [37] Li KC, Chang YH, Yeh CL, et al. Healing of osteo-porotic bone defects by baculovirus-engineered bone marrow-derived MSCs expressing MicroRNA sponges[J]. Biomaterials, 2016, 74:155-166. (本文采编 王晴) |